![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_9d111ca31c6b5557bbe95cc7cad92c76.svg) | Vatalanib | IC50 | 140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_aa4ae66a17e1730306dedb6ebaeee891.svg) | 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_6925afc0497f067aee8668b4ed241d61.svg) | N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 14100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_7c1f47f3c7bae38fb065c983ece631c1.svg) | Vandetanib | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 5.4 [1], 8.19 [2], 15.97 [3], 19.0 [4], 35.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_f8ca8018290f1dd80c8639283c8f8eae.svg) | 2-{[(Pyridin-4-yl)methyl]amino}-N-(quinolin-3-yl)benzamide | IC50 | 15.0 [1], 160.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_8a69b3902a36c5bcb114db8f49f8eabe.svg) | Semaxanib | IC50 | 8.0 [1], 43.0 [2], 3000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_4e38800d1c310079b3b3e65c5db78d0d.svg) | Linifanib | IC50 | 3.0 [1], 37.0 [2], 70.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_9f36928c7798762644284deeae8e4225.svg) | (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]pentanediamide | IC50 | 102700.0 [1], 160000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_c8494007663098abb5d227cb27cc738b.svg) | Sorafenib | IC50 | 18.0 [1], 31.0 [2], 165.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_8edb893ba88c5700603edef201da4265.svg) | Nintedanib | IC50 | 23.4 [1], 34.0 [2], 104.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_173905a1d8206fe6271a8ee9486c99d9.svg) | Foretinib | IC50 | 0.8 [1], 6.8 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_e610c2d08ff0a822b4e8c7ed2a80b2b9.svg) | N4-(3-Bromophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 16000.0 [1], 19200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_aad5240e9c96fb698e391fe66cef5fea.svg) | 4-N-(3-Bromophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_4e53db16979c93e82f7fbd654a494204.svg) | 4-N-(3-Bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 31100.0 [1], 45900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_5339c0bf9e9ecf55e5dd49fd8c06c8ec.svg) | c[YYDEGLEE]-NH2 | IC50 | 23000.0 [1], 32000.0 [2], 39900.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_7de5848be93196a6906eba944a298431.svg) | Sunitinib | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_7de5848be93196a6906eba944a298431.svg) | Sunitinib | Ki | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_1c0dbc70a65a3eccf3e39ecce75f7f37.svg) | Pazopanib | IC50 | 10.0 [1], 98.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_47d151d561f848592c41ab2966c047a4.svg) | Dovitinib | IC50 | 3.0 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_c92f4bc6d141b8aeb107ab58dde46ce7.svg) | Motesanib | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_ae3c621c3ca0049e7a4045efa2e650e7.svg) | Tivozanib | IC50 | 0.21 [1], 6.26 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_3b9e10412a2d6240147321cb2601cee1.svg) | VEGF receptor tyrosine kinase inhibitor III | IC50 | 1.0 [1], 170.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_2f15fb478c8045b6bf5d450f1eb5924b.svg) | Lucitanib | IC50 | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_9c062cd6c7c1362062730d56f1c53648.svg) | N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[2-(triazol-1-yl)ethoxy]quinazolin-4-amine | IC50 | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_580efe2e66439369c377fd174fde96fb.svg) | Ilorasertib | IC50 | 1.25 [1], 32.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_f1099aa3bd39876799914a83803e440e.svg) | Tak-593 | IC50 | 3.2 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_229be97168f5a1e19a21ea31c162ddf6.svg) | 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 7.76 [1], 8.51 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_bbb936490cb2d36df2f50d54114bf2ad.svg) | 1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_a1c584a0569c487c0d6e91dd89b49d93.svg) | 2-Benzyl-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_2bced59f0544a1d307819661165e96b1.svg) | 6-(2-Phenylethyl)-4-N-[3-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_56be305ce0bc0e4819b6a91347a654e8.svg) | 2-(2-Chlorobenzyl)-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 26800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_f441851b7d3335f928c0771fb5465528.svg) | N-(4-Chloro-2-fluorophenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine | IC50 | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_1eea5d53cfa9292d5b7c2a6489c9d3b2.svg) | 4-N-(3-Bromo-4-fluorophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_fc07e0a3a4153d0d4fe1682eae2e3d4c.svg) | 1-Methyl-1-[[5-[7-[(4-methylpiperazin-1-yl)methyl]-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]thiophen-2-yl]methyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_66456099f0d26a37ee3c158b92af7592.svg) | (4S)-5-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-Amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoic acid | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_72d49d50cb039f20084db43546076f56.svg) | 4-N-[4-Fluoro-3-(trifluoromethyl)phenyl]-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_ea05fd4048f493678664297a5b3ae7b6.svg) | 4-N-(3-Bromophenyl)-6-[(2,4-dichlorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_fffc2cd93cf9cf2480aabcb15d1ebe5e.svg) | N4-(3-Bromophenyl)-2-(naphthalen-2-ylmethyl)-1H-indole-4,6-diamine | IC50 | 15200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_29ad3a4ebcaa4064db5843d08aa2cb66.svg) | N4-(3-Bromophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 45100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_25fabe8db73c2762558342fcf994ffe8.svg) | 4-N-(3-Ethynylphenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_57025fc92e16ed4c4ec841dce5a0136e.svg) | 4-N-(4-Chloro-2-fluorophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_bc248663040c83d4b078eec03de96a06.svg) | N4-1H-Indol-5-yl-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_3e3ec3f6b15bbe00f869d3141f5a04a2.svg) | Anilinoquinazoline deriv. 21 | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_63216cb9f6b3fffcaebccb81fc8effbe.svg) | Anilinoquinazoline deriv. 22 | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_f8eae3bc9bf99cdf9a370bf2e202458c.svg) | Anilinoquinazoline deriv. 28 | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_4b982052d39469ba4c3ef93d7649b3c4.svg) | Anilinoquinazoline deriv. 32 | IC50 | 1500.0 [1], 15000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_9a52b202d60d4e94b9b65b18a6931448.svg) | N-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-4-(thieno[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide | IC50 | 19.8 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_70ec8b2d59256ac155ebd7908cf0a8aa.svg) | c[YYAEGLEE]-NH2 | IC50 | 25000.0 [1], 35000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_c15e34cab725a87fea8e102e2a4c7f78.svg) | 3-[(3S,6S,9S,12S,15S,18S,21S,26S)-26-Carbamoyl-12-(2-carboxyethyl)-15-(carboxymethyl)-18,21-bis[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclohexacos-3-yl]propanoic acid | IC50 | 101000.0 [1], 105000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_bf69394ee398f8e926b31fa128d98c9f.svg) | (3R,6S,9S,14S,17S,23S,26S)-9-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-3-(4-aminobutyl)-N-[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-17-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-23-(1H-imidazol-5-ylmethyl)-2,5,8,16,19,22,25-heptaoxo-1,4,7,15,18,21,24-heptazabicyclo[24.3.0]nonacosane-14-carboxamide | IC50 | 91600.0 [1], 105500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_906fc392cce8e9e82d33c21e76a426cc.svg) | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 36500.0 [1], 42300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_2f0ed0804fe47686d3c3cb92edc43004.svg) | (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 61200.0 [1], 61800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_946e115a201722529a51e204db5c6d7d.svg) | (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamidopent-4-enoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxopent-4-en-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]pentanediamide | IC50 | 76800.0 [1], 98800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_084a8d73936803e3562e6004b37c79f7.svg) | (2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 90300.0 [1], 109500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_45bfb773de359f2d6c40de53bc1f5eda.svg) | (3S,6S,9S,14S,17S,23S,26S,29S)-9-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-3-(4-aminobutyl)-N-[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-17,23-bis(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-26-(1H-imidazol-5-ylmethyl)-2,5,8,12,16,19,22,25,28-nonaoxo-1,4,7,11,15,18,21,24,27-nonazabicyclo[27.3.0]dotriacontane-14-carboxamide | IC50 | 87600.0 [1], 93200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_ec29341adb1f72409ddee5def46fcd32.svg) | Methyl (2S,4R)-1-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]-4-hydroxypyrrolidine-2-carboxylate | IC50 | 10.0 [1], 15.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_261fc8f7c289b040d810e074b2e9c5f2.svg) | N-[2-(Diethylamino)ethyl]-7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 5.0 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_85d7b5309d7f7ad9fe5fec91f03478da.svg) | N-[3-(Diethylamino)propyl]-7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 3.0 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_6c5c75421ebb2f67553bd7cb5dfa1075.svg) | 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-(2H-tetrazol-5-yl)propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 4.0 [1], 20.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_b05ccd7efb85dc68fd36cbcf9ce78e5d.svg) | 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[2-(2H-tetrazol-5-yl)ethyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 10.0 [1], 19.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_007e75eb809ba3416b6c91063d3e5235.svg) | Ethyl 2-[4-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]piperazin-1-yl]acetate | IC50 | 5.0 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_db4a4c0d25dc5ebc99e128829d6ba80d.svg) | 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-[3-(hydroxymethyl)piperidin-1-yl]propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 3.0 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_59f2cb32e33fe670f179e08466f80b90.svg) | 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-[2-(hydroxymethyl)morpholin-4-yl]propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 10.0 [1], 15.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_29ecb913aa6daaf941b9fd2e8fc2ccbf.svg) | Methyl 2-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propylamino]acetate | IC50 | 6.0 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_2251489ab83c87bfd7bd3d25883f6011.svg) | Methyl 2-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 9.0 [1], 14.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_0eb4622c44fe96ccdb32065933f8148d.svg) | Ethyl 4-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl]piperazine-1-carboxylate | IC50 | 13.0 [1], 14.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_d5151829eae0090ba83e2b980c30369f.svg) | Ethyl 4-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]piperazine-1-carboxylate | IC50 | 9.0 [1], 14.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_e41675fa095afdd54b475397ea1abba6.svg) | Methyl 2-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propylamino]acetate | IC50 | 8.0 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_f480d6bd4573247391282d1007adae2c.svg) | Methyl 2-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 10.0 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_3a3b403cccac72f2430947975282bf0e.svg) | Methyl 2-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 11.0 [1], 17.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_0b29680e038f00e0b1dec5afba6517cd.svg) | Methyl 1-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]pyrrolidine-3-carboxylate | IC50 | 8.0 [1], 17.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_1423d5b40526f5a33173336db435ca40.svg) | Ethyl 2-[4-[2-[4-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]piperazin-1-yl]acetyl]piperazin-1-yl]acetate | IC50 | 10.0 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_4e637f39d0d2dc01271a487a83368bfb.svg) | Ethyl 2-[4-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]piperazin-1-yl]acetate | IC50 | 17.0 [1], 112.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_814c953951c4ade35a5d1b18fac0d87e.svg) | Methyl 2-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethylamino]acetate | IC50 | 9.0 [1], 13.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_9216b6bba5f7fe20f9f33ce3a07decf4.svg) | N-(2-Aminoethyl)-7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 11.0 [1], 15.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_7fb79a4f6869608753afb65645c2da6b.svg) | Tert-butyl N-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl]carbamate | IC50 | 60.0 [1], 69.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_0922396a042586202792fc6be08c0b8d.svg) | 7-[3-Fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-(4-methylpiperazin-1-yl)propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 6.0 [1], 11.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_ee7ada059959dc952d83482f1f7c475d.svg) | 2,3,7,8-Tetrachlorodibenzo-P-dioxin | Ki | 0.7 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_e2f99194617c96946324b426e112d809.svg) | Erlotinib | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_6724fa0e470bbc3197fba3b69ba792aa.svg) | Hematoxyline | IC50 | 2900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_089229f730995f82fe9d2e6ca72052fd.svg) | Digitin | Ki | 1001.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_d2aaae557a3df420b61b69998679cc44.svg) | Dorsomorphin | IC50 | 11.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_e1bd3c1d60717a09fae0532edc016b5c.svg) | Axitinib | IC50 | 0.1 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_12fa190f2d2e4b2561e24185e6a9c597.svg) | Nintedanib esylate | IC50 | 34.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_fb653bf3974ba8878f0badcb4c717a18.svg) | Cediranib | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_34ec291e290db2e13648ccc8dee7e3a5.svg) | Cabozantinib | IC50 | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_4e9df3bd1ea0920231ce5d4b41666b94.svg) | Ponatinib | IC50 | 20.9 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_64228e39ff99d82c03e732fc55e098b9.svg) | Chir-99021 | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_86afa169fbf5024375ee5d399dedddf5.svg) | Saracatinib | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_0a83b01cf93719a90ccaeda771089c43.svg) | Doramapimod | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_1575317431cf6bb218d1789cccd6e0ea.svg) | Quizartinib | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_37acee0cd10541aa0b3bd57948b54806.svg) | Orantinib | IC50 | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_e68e8f660a42b0d769ec0962d14c3289.svg) | Brivanib | Ki | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_308f46b4c40c812c872cfe130b3fc720.svg) | 3,9-Bis((ethylthio)methyl)-K-252a | IC50 | 209.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_c38cbdee4404993837adfc282c860ec1.svg) | Nvp-tae 684 | IC50 | 872.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_739061f31935a6870017b908418f40b7.svg) | (R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 59.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_94feb385cecaa610e1d68d9fb9d55ef3.svg) | Pyridone 6 | IC50 | 1520.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-1_fa37ae125bcd4e6df1af4be57fbea491.svg) | 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 10.0 [1] |